143 Views
Theodore Ruel, MD
Professor
University of California San Francisco
San Francisco, California
Disclosure: ViiV : I serve as protocol chair for a regulatory trial for a drug that is manufactured by ViiV/GSK, that also makes cabotegravir. The trial is partially funded by Viiv-GSK through the NIH/IMPAACT tiral network, but I do not receive any direct funding. (Status: Ongoing), Other Financial or Material Support (Status: Ongoing)